Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T00:16:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information on who to contact for questions about joining the study and where it is taking place, with a revision from v2.12.2 to v2.13.2.
    Difference
    1%
    Check dated 2024-12-09T21:14:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.1 to 2.12.2.
    Difference
    0.0%
    Check dated 2024-11-25T13:55:24.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated with a new Plain Language Summary and a revision to version 2.12.1, while previous revisions and dates have been removed.
    Difference
    0.2%
    Check dated 2024-11-04T09:36:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The Medizinische Universitat Wien has added new data regarding adverse events experienced by participants in a clinical study, including the number of participants who experienced adverse events and those who discontinued treatment due to these events, with follow-up periods of up to 46 months.
    Difference
    4%
    Check dated 2024-10-17T20:30:14.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new entry has been added for a completed study in København Ø, Denmark, with an updated revision to v2.11.2, while a previous recruiting entry from Copenhagen East has been removed.
    Difference
    0.5%
    Check dated 2024-10-03T05:44:37.000Z thumbnail image

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.